echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Int J Radiat Oncol Biol Phys: Whether advanced pancreatic cancer is suitable for radiotherapy and chemotherapy, the neutrophil count has a hint!

    Int J Radiat Oncol Biol Phys: Whether advanced pancreatic cancer is suitable for radiotherapy and chemotherapy, the neutrophil count has a hint!

    • Last Update: 2021-04-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Pancreatic cancer is one of the leading causes of cancer-related deaths worldwide, with a five-year survival rate of no more than 10%.


    Pancreatic Cancer Management

    In this case, it is particularly necessary to be able to predict overall survival (OS), identify biomarkers that require enhanced induction regimens and patients who benefit from radiotherapy and chemotherapy .


    In this case, it is particularly necessary to be able to predict overall survival (OS), identify biomarkers that require enhanced induction regimens and patients who benefit from radiotherapy and chemotherapy.


    Int J Radiat Oncol Biol Phys Int J Radiat Oncol Biol Phys baseline neutrophil count can predict the OS of LAPC patients

    An international multicenter randomized phase 3 trial (LAP07) enrolled 442 patients with LAPC.


    Prognosis of patients with or without neutropenia at baseline

    Prognosis of patients with or without neutropenia at baseline

    Among 442 patients, 47 (11%) patients with neutrophilia had poorer OS (median 8.


    The OS of 47 patients (11%) with neutrophilia was poor.


    Cumulative recurrence rate of patients with or without systemic inflammation (SI) treated with CT or RCT

    Cumulative recurrence rate of patients with or without systemic inflammation (SI) treated with CT or RCT

    In addition, the increase in neutrophil count also indicates that the efficacy of radiotherapy and chemotherapy for local control will be reduced .


    Elevated neutrophil count also indicates a decrease in the efficacy of radiotherapy and chemotherapy for local control

    In summary, the study shows that in LAPC patients, baseline neutropenia and absolute increase in neutrophil counts are associated with worse OS .


    In LAPC patients, baseline neutropenia and absolute increase in neutrophil count are associated with worse OS.


    Original source:

    Schernberg Antoine, Vernerey Dewi, Goldstein David et al.


    org/10.
    1016/j.
    ijrobp.
    2021.
    01.
    052" target="_blank" rel="noopener">Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.